NCT05392413View on ClinicalTrials.gov

Immune Indicator Model for Predicting Efficacy of PD-1 Monoclonal Antibody

RecruitingOBSERVATIONAL

Enrollment

200

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions

Esophageal Squamous Cell CarcinomaPD-1 Inhibitor

Trial Locations (1)

Unknown

RECRUITING

Nanfang Hospital, Guangzhou

All Listed Sponsors

lead

Nanfang Hospital, Southern Medical University

OTHER